5. References

  1. IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Available at: https://www-micromedexsolutions-com.libproxy.uthscsa.edu/ (cited:  September 11, 2023).
  2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2023. Available at:  http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 11, 2023.
  3. Paliperidone palmitate extended-release injection suspension (Invega® Sustenna®) package insert. Janssen Pharmaceuticals, July 2022.
  4. Aripiprazole intramuscular extended-release injection (Abilify Asimtufii®) package insert. Otsuka America Pharmaceutical, Inc., August 2023.
  5. Aripiprazole intramuscular extended-release injection (Abilify Maintena®) package insert. Otsuka America Pharmaceutical, Inc., February 2023.
  6. Risperidone long-acting injection (Risperdal Consta®) package insert. Janssen Pharmaceuticals, Inc., February 2021.
  7. Risperidone extended-release intramuscular microsphere injection (Rykindo®) package insert. Shandong Luye Pharmaceutical Co., ltd., May 2023.
  8. Risperidone extended-release subcutaneous injection (Uzedy®) package insert. Teva Pharmaceuticals, Inc., May 2023.
  9. Aripiprazole lauroxil intramuscular extended-release injection (Aristada®) package insert. Alkermes, Inc., March 2021.
  10. Aripiprazole lauroxil intramuscular extended-release (Aristada Initio®) package insert. Alkermes, Inc., March 2021.
  11. Olanzapine extended release injectable suspension (Zyprexa® Relprevv™) package insert. Eli Lilly and Company, November 2021.
  12. Paliperidone palmitate extended-release injection suspension (Invega Hafyera®) package insert. Janssen Pharmaceuticals, August 2021.
  13. Paliperidone palmitate extended-release suspension (Invega Trinza®) package insert. Janssen Pharmaceuticals, August 2021.
  14. Risperidone long-acting injection (Perseris®) package insert. Indivior Inc., December 2022.
  15. The Parameters Workgroup of the Psychiatric Executive Formulary Committee, Health and Specialty Care Division, Texas Health and Human Services Commission. Psychotropic medication utilization parameters for children and youth in Texas public behavioral health (6th version). (June 2019) Available at: https://hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf. Accessed September 17, 2023.